UCSF Navigation Bar

UCSF Departments of Pathology & Laboratory Medicine Home Page

Lab Manual for UCSF Clinical Laboratories

Lab Manual for SFGH

Internal Resources

HEPATITIS B SURFACE ANTIBODY (HBS-AB)

Item Value
Available Stat? No
Test code HBSB
Performed by? Chemistry
Sendout? no
Price range $$
In House Availability Daily, Mon - Fri
Principle Microparticle Chemiluminometric Immunoassay.
Interpretation The antibody appears during convalescence or following successful immunization. It is usually long-lived, but titers decrease with time and may eventually become undetectable. This antibody is protective against hepatitis B infection. A positive result indicates immunity. A borderline result indicates inadequate immunity and will be reported as "IDET" = Indeterminate. If clinically indicated, please resubmit in 4 weeks).

To monitor recovery from acute hepatitis B, to evaluate hepatitis B immune status, or for pre-vaccination screening.
Container type gold top gel tube
Amount to Collect 2 mL
Sample type Blood
Normal range
< 5 mIU/mL Negative
5-11.9 mIU/mL Indeterminant
≥ 12 mIU/mL Positive

Synonyms HBS-AB;
Stability 2 days at 2-8°C and 1 month at -20°C.
References 1. Advia Centaur Assay Manual. Siemens Medical Solutions Diagnostics, Malvern, PA. Pub# 113353, Rev. A, 2004-05

2. Juszczyk, J. Clinical Course and Consequences of Hepatitis B Infection. Vaccine 18:523-525 (2000.

3. Jilig W, Schmidt M, Deinhart F. Decline or anti-HBs after hepatitis B vaccination and timing of revaccination. Lancet 335:173-174 (1990).

4. Zachoval R, Jilig W, et al.: Passive/active immunization against hepatitis B. J Infect Dis 150(1):112-117 (1984).
CPT coding 86706
Last Updated 10/22/2012 6:25:53 PM
Search Our Test Menu
UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center